financetom
Business
financetom
/
Business
/
Here's what experts have to say on IDBI Bank stake sale to LIC
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Here's what experts have to say on IDBI Bank stake sale to LIC
Jun 22, 2018 2:04 PM

A quarter of its loan book gone bad, a net loss of over Rs 5,600 crore in just the Q4, a halt in corporate lending and a shrinkage in international operations.

IDBI Bank clearly finds itself in choppy waters and the government finds itself desperately looking for a solution.

Reports coming in today indicate that the government is considering selling a significant stake in IDBI Bank to Life Insurance Corporation (LIC).

But sources tell CNBC-TV18 that while discussions are on, no proposal has been taken to the LIC board yet. A proposal once finalised will first have to be cleared by LIC's investment & strategy committee and the quantum of stake to be bought will depend on negotiations & decision by the committee.

Speaking to CNBC-TV18, BP Sharma, former executive director at Bank of India, said that news is speculative and definitely government is keen to reduce stake in IDBI Bank, which is not coming strictly a public sector bank.

Sharma said privatisation of the bank is not feasible in the near future and that is why government is trying to reduce stake and there is nothing wrong in that.

AK Bhattacharya, Editorial Director at Business Standard, blames government for not privatising IDBI Bank.

Government is trying to shore up its disinvestment revenues through this and around Rs 10,000-11,000 crore is likely to be garnered through this sale, Sharma said to CNBC-TV18.

Bhattacharya said, "LIC need to be very sure that their investment needs to safe, sound and prudent. I see this attempt as using regulatory forbearance to get the country’s largest insurer to have a stake in the bank."

He further added, “I hope Insurance Regulatory and Development Authority (IRDA) takes necessary note of this and it's not a good sign."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ryder System Names COO, CFO
Ryder System Names COO, CFO
Dec 16, 2024
05:25 PM EST, 12/16/2024 (MT Newswires) -- Ryder System (R) said Monday it has appointed John Diez as president and chief operating officer, starting Jan. 1, 2025. Cristina Gallo-Aquino, who most recently held the role of senior vice president, controller, and principal accounting officer, will succeed Diez as executive vice president and chief financial officer, also from Jan. 1, the...
Ozy Media founder Carlos Watson sentenced to almost 10 years for fraud
Ozy Media founder Carlos Watson sentenced to almost 10 years for fraud
Dec 16, 2024
NEW YORK, Dec 16 (Reuters) - Ozy Media founder Carlos Watson was sentenced on Monday to nearly 10 years in prison, after a jury found him guilty in July of lying to investors about the now-defunct startup's finances and sham deals with Google and Oprah Winfrey. U.S. District Judge Eric Komitee handed down the 116-month sentence at a hearing in...
Quipt Home Medical Posts Wider Fourth-quarter Net Loss, Higher Revenue
Quipt Home Medical Posts Wider Fourth-quarter Net Loss, Higher Revenue
Dec 16, 2024
05:26 PM EST, 12/16/2024 (MT Newswires) -- Quipt Home Medical ( QIPT ) after trade Monday reported a wider fourth-quarter net loss despite higher revenue. The company said it lost US$3.2 million compared with US$1.3 million in the year-prior quarter. Revenue for the quarter ended Sept. 30 rose 3% to US$61.3 million from US$59.6 million. Sequential organic revenue growth was...
Amphastar Pharmaceuticals Insider Sold Shares Worth $672,815, According to a Recent SEC Filing
Amphastar Pharmaceuticals Insider Sold Shares Worth $672,815, According to a Recent SEC Filing
Dec 16, 2024
05:27 PM EST, 12/16/2024 (MT Newswires) -- Rong Zhou, Senior Executive Vice President, Production Center, on December 12, 2024, sold 15,000 shares in Amphastar Pharmaceuticals ( AMPH ) for $672,815. Following the Form 4 filing with the SEC, Zhou has control over a total of 223,137 shares of the company, with 118,469 shares held directly and 104,668 controlled indirectly. SEC...
Copyright 2023-2026 - www.financetom.com All Rights Reserved